IL-8, IL-10, TGF-β, and GCSF levels were increased in severe persistent allergic asthma patients with the anti-IgE treatment

Mediators of Inflammation

Volumn 2012, Issue , 2012, Pages

  Yalcin, Arzu D ^a   Bisgin, Atil ^b,c   Gorczynski, Reginald M ^d  

^a Antalya Training and Research Hospital ^*  (Turkey)

^b LINKÖPING UNIVERSITY   (Sweden)

^c CUKUROVA UNIVERSITY   (Turkey)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FLUTICASONE; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 8; METHYLPREDNISOLONE; OMALIZUMAB; SALMETEROL; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; ANTI IGE ANTIBODIES; ANTI-IGE ANTIBODIES; ANTIIDIOTYPIC ANTIBODY; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; IL10 PROTEIN, HUMAN;

ADULT; ALLERGIC ASTHMA; ALLERGIC DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; IMMUNOTHERAPY; MALE; PATHOGENESIS; PRIORITY JOURNAL; SKIN TEST; ADOLESCENT; ASTHMA; BLOOD; IMMUNOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY;

ADOLESCENT; ADULT; ANTIBODIES, ANTI-IDIOTYPIC; ASTHMA; C-REACTIVE PROTEIN; CYTOKINES; FEMALE; FORCED EXPIRATORY VOLUME; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-10; INTERLEUKIN-8; MALE; MIDDLE AGED; TRANSFORMING GROWTH FACTOR BETA;

MLCS; MLOWN;

EID: 84872154660     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2012/720976     Document Type: Article

References (48)

1. Anderson G. P., Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. The Lancet 2008 372 9643 1107 1119 2-s2.0-52049087356 10.1016/S0140-6736(08)61452-X
2. Lotvall J., Akdis C., Bacharier L. B., Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. American Academy of Allergy, Asthma, and Immunology 2011 127 2 355 360 10. 1016/j.jaci. 2010. 11. 037
3. Larche M., Robinson D. S., Kay A. B., The role of T lymphocytes in the pathogenesis of asthma. The Journal of Allergy and Clinical Immunology 2003 111 450 463 (Pubitemid 36337859)
4. Epstein M. M., Targeting memory Th2 cells for the treatment of allergic asthma. Pharmacology & Therapeutics 2006 109 107 136 10. 1016/j.pharmthera. 2005. 06. 006 (Pubitemid 41742235)
5. Robinson D. S., Hamid Q., Ying S., Tsicopoulos A., Barkans J., Bentley A. M., Corrigan C., Durham S. R., Kay A. B., Predominant T(H2)-like bronchoalveolar T-lymphocyte population in atopic asthma. The New England Journal of Medicine 1992 326 5 298 304 2-s2.0-0026610142
6. Wills-Karp M., Finkelman F. D., Untangling the complex web of IL-4- and IL-13-mediated signaling pathways. Science Signaling 2008 1 51 pe55 2-s2.0-58749091674 10.1126/scisignal.1.51.pe55
7. Cooper A. M., Khader S. A., IL-12p40: an inherently agonistic cytokine. Trends in Immunology 2007 28 1 33 38 2-s2.0-33845606612 10.1016/j.it.2006.11.002 (Pubitemid 44960157)
8. Kumar R. K., Webb D. C., Herbert C., Foster P. S., Interferon- γ as a possible target in chronic asthma. Inflammation and Allergy 2006 5 4 253 256 2-s2.0-33845604366 10.2174/187152806779010909 (Pubitemid 44941936)
9. John M., Lim S., Seybold J., Jose P., Robichaud A., O'Connor B., Barnes P. J., Chung K. F., Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1 α granulocyte-macrophage colony-stimulating factor, and interferon- γ release from alveolar macrophages in asthma. American Journal of Respiratory and Critical Care Medicine 1998 157 1 256 262 2-s2.0-0031943945 (Pubitemid 28071290)
10. Pene J., Chevalier S., Preisser L., Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. The Journal of Immunology 2008 180 7423 7430
11. + TH2 memory/ effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. Journal of Experimental Medicine 2010 207 11 2479 2491 2-s2.0-78149326083 10.1084/jem.20101376
12. Yamashita N., Tashimo H., Ishida H., Kaneko F., Nakano J., Kato H., Hirai K., Horiuchi T., Ohta K., Attenuation of airway hyperresponsiveness in a murine asthma model by neutralization of granulocyte-macrophage colony-stimulating factor (GM-CSF). Cellular Immunology 2002 219 2 92 97 2-s2.0-0036826485 10.1016/S0008-8749(02)00565-8 (Pubitemid 36259613)
13. Dente F. L., Carnevali S., Bartoli M. L., Cianchetti S., Bacci E., Di Franco A., Vagaggini B., Paggiaro P., Profiles of proinflammatory cytokines in sputum from different groups of severe asthmatic patients. Annals of Allergy, Asthma and Immunology 2006 97 3 312 320 2-s2.0-33749175394 (Pubitemid 44476566)
14. Shute J. K., Vrugt B., Lindley I. J. D., Holgate S. T., Bron A., Aalbers R., Djukanović R., Free and complexed interleukin-8 in blood and bronchial mucosa in asthma. American Journal of Respiratory and Critical Care Medicine 1997 155 6 1877 1883 2-s2.0-0030922396 (Pubitemid 27256112)
15. Berry M. A., Hargadon B., Shelley M., Evidence of a role of tumor necrosis factor alpha in refractory asthma. The New England Journal of Medicine 2006 354 697 708 (Pubitemid 43247140)
16. Jatakanon A., Uasuf C., Maziak W., Lim S., Chung K. F., Barnes P. J., Neutrophilic inflammation in severe persistent asthma. American Journal of Respiratory and Critical Care Medicine 1999 160 5 I 1532 1539 2-s2.0-0032698182
17. Saha S. K., Doe C., Mistry V., Siddiqui S., Parker D., Sleeman M., Cohen E. S., Brightling C. E., Granulocyte-macrophage colony-stimulating factor expression in induced sputum and bronchial mucosa in asthma and COPD. Thorax 2009 64 8 671 676 2-s2.0-68049139146 10.1136/thx.2008.108290
18. Silvestri M., Bontempelli M., Giacomelli M., Malerba M., Rossi G. A., Di Stefano A., Rossi A., Ricciardolo F. L. M., High serum levels of tumour necrosis factor- α and interleukin-8 in severe asthma: markers of systemic inflammation? Clinical and Experimental Allergy 2006 36 11 1373 1381 2-s2.0-33750540593 10.1111/j.1365-2222.2006.02502.x (Pubitemid 44674121)
19. Fahy J. V., Fleming H. E., Wong H. H., Liu J. T., Su J. Q., Reimann J., Fick R. B., Boushey H. A., The effect of an anti-IgE monoclonal antibody on the early- and late- phase responses to allergen inhalation in asthmatic subjects. American Journal of Respiratory and Critical Care Medicine 1997 155 6 1828 1834 2-s2.0-0030956903 (Pubitemid 27256105)
20. Noga O., Hanf G., Brachmann I., Klucken A. C., Kleine-Tebbe J., Rosseau S., Kunkel G., Suttorp N., Seybold J., Effect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma. Journal of Allergy and Clinical Immunology 2006 117 6 1493 1499 2-s2.0-33646914451 10.1016/j.jaci.2006.02.028 (Pubitemid 43795739)
21. Hanf G., Brachmann I., Kleine-Tebbe J., Seybold J., Kunkel G., Suttorp N., Noga O., Omalizumab decreased IgE-release and induced changes in cellular immunity in patients with allergic asthma. Allergy 2006 61 9 1141 1144 2-s2.0-33746800638 10.1111/j.1398-9995.2006.01180.x (Pubitemid 44175224)
22. Yalcin A. D., Bisgin A., Cetinkaya R., Gumuslu S., Clinical efficacy of omalizumab in severe persistent asthma and co-morbid conditions. EAACI. In press 10. 3252/pso.eu. 30eaaci
23. Roca J., Sanchis J., Agusti-Vidal A., Spirometric reference values from a Mediterranean population. Clinical Respiratory Physiology 1986 22 3 217 224 2-s2.0-0022654287 (Pubitemid 16116729)
24. Hollander C., Sitkauskiene B., Sakalauskas R., Westin U., Janciauskiene S. M., Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma. Respiratory Medicine 2007 101 9 1947 1953 2-s2.0-34547492893 10.1016/j.rmed.2007.04.010 (Pubitemid 47163535)
25. Krogulska A., Wasowska-Królikowska K., Polakowska E., Chrul S., Cytokine profile in children with asthma undergoing food challenges. Journal of Investigational Allergology and Clinical Immunology 2009 19 1 43 48 2-s2.0-62549091503
26. Litonjua A. A., Sparrow D., Guevarra L., O'Connor G. T., Weiss S. T., Tollerud D. J., Serum interferon- γ is associated with longitudinal decline in lung function among asthmatic patients: the Normative Aging Study. Annals of Allergy, Asthma and Immunology 2003 90 4 422 428 2-s2.0-0345269120 (Pubitemid 36459048)
27. Nakamura H., Weiss S. T., Israel E., Luster A. D., Drazen J. M., Lilly C. M., Eotaxin and impaired lung function in asthma. American Journal of Respiratory and Critical Care Medicine 1999 160 6 1952 1956 2-s2.0-0033430375 (Pubitemid 30004702)
28. Tateno H., Nakamura H., Minematsu N., Nakajima T., Takahashi S., Nakamura M., Fukunaga K., Asano K., Lilly C. M., Yamaguchi K., Plasma eotaxin level and severity of asthma treated with corticosteroid. Respiratory Medicine 2004 98 8 782 790 2-s2.0-3042692721 10.1016/j.rmed.2004.01.005 (Pubitemid 38842783)
29. Holgate S. T., Epithelium dysfunction in asthma. Journal of Allergy and Clinical Immunology 2007 120 6 1233 1244 2-s2.0-36849031788 10.1016/j.jaci.2007. 10.025 (Pubitemid 350225687)
30. Nocker R. E. T., Schoonbrood D. F. M., van de Graaf E. A., Hack C. E., Lutter R., Jansen H. M., Out T. A., Interleukin-8 in airway inflammation in patients with asthma and chronic obstructive pulmonary disease. International Archives of Allergy and Immunology 1996 109 2 183 191 2-s2.0-0030048179 (Pubitemid 26029386)
31. Hsu H. C., Yang P. A., Wang J., Wu Q., Myers R., Chen J., Yi J., Guentert T., Tousson A., Stanus A. L., Le T. V. L., Lorenz R. G., Xu H., Kolls J. K., Carter R. H. R. H., Chaplin D. D., Williams R. W., Mountz J. D., Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nature Immunology 2008 9 2 166 175 2-s2.0-38349178776 10.1038/ni1552
32. Sun Y. C., Zhou Q. T., Yao W. Z., Sputum interleukin-17 is increased and associated with airway neutrophilia in patients with severe asthma. Chinese Medical Journal 2005 118 11 953 956 2-s2.0-20944441664
33. Trivedi S. G., Lloyd C. M., Eosinophils in the pathogenesis of allergic airways disease. Cellular and Molecular Life Sciences 2007 64 10 1269 1289 2-s2.0-34249053866 10.1007/s00018-007-6527-y (Pubitemid 46791053)
34. Minshall E. M., Leung D. Y. M., Martin R. J., Song Y. L., Cameron L., Ernst P., Hamid Q., Eosinophil-associated TGF- β 1 mRNA expression and airways fibrosis in bronchial Asthma. American Journal of Respiratory Cell and Molecular Biology 1997 17 3 326 333 2-s2.0-0031226757 (Pubitemid 127500837)
35. Cho J. Y., Miller M., Baek K. J., Han J. W., Nayar J., Lee S. Y., McElwain K., McElwain S., Friedman S., Broide D. H., Inhibition of airway remodeling in IL-5-deficient mice. Journal of Clinical Investigation 2004 113 4 551 560 2-s2.0-11144354691 10.1172/JCI200419133 (Pubitemid 38542504)
36. Brightling C. E., Bradding P., Symon F. A., Holgate S. T., Wardlaw A. J., Pavord I. D., Mast-cell infiltration of airway smooth muscle in asthma. The New England Journal of Medicine 2002 346 22 1699 1705 2-s2.0-0037198418 10.1056/NEJMoa012705 (Pubitemid 34547483)
37. Chung F., Anti-inflammatory cytokines in asthma and allergy: Interleukin-10, interleukin-12, interferon- γ Mediators of Inflammation 2001 10 2 51 59 2-s2.0-0034989299 10.1080/09629350120054518 (Pubitemid 32522160)
38. Yalcin A. D., Bisgin A The relation of sTRAIL levels and quality of life in severe persistent allergic asthma patients using omalizumab. Medical Science Monitor 2012 18 8 LE9 LE10
39. Yalcin A. D., Bisgin A., Omalizumab: anti-IgE therapy in severe allergic conditions. Allergy & Therapy Journals 3, article 120
40. Corrigan C. J., Kay A. B., CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. American Review of Respiratory Disease 1990 141 4 970 977 2-s2.0-0025265156 (Pubitemid 20157728)
41. Saito H., Hayakawa T., Mita H., Yui Y., Shida T., Augmentation of leukotriene C4 production by gamma interferon in leukocytes challenged with an allergen. International Archives of Allergy and Applied Immunology 1988 87 3 286 293 2-s2.0-0024246283 (Pubitemid 19010888)
42. Friebe A., Volk H. D., Stability of tumor necrosis factor α interleukin 6, and interleukin 8 in blood samples of patients with systemic immune activation. Archives of Pathology and Laboratory Medicine 2008 132 11 1802 1806 2-s2.0-55549133952 10.1043%2F1543-2165-132.11.1802
43. Yalcin A. D., Gorczynski R. M., Parlak G. E., Kargi A., Bisgin A., Şahin E., Kose S., Gumuslu S., Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment. Clinical Laboratory 2012 58 1-2 89 96
44. Yalcin A. D., Bisgin A., Kargi A., Gorczynski R. M., Serum soluble TRAIL levels in patients with severe persistent allergic asthma: its relation to Omalizumab treatment. Medical Science Monitor 2012 18 3 11 15
45. Yalcin A. D., Gumuslu S., Parlak G. E., Bisgin A., Yildiz M., Kargi A., Gorczynski R. M., Systemic levels of ceruloplasmin oxidase activity in allergic asthma and allergic rhinitis. Immunopharmacol Immunotoxicol 2012 34 6 1047 1053
46. Bates C. A., Silkoff P. E., Exhaled nitric oxide in asthma: from bench to bedside. Journal of Allergy and Clinical Immunology 2003 111 2 256 262 2-s2.0-0037329738 10.1067/mai.2003.103 (Pubitemid 36228543)
47. Pepys M. B., Baltz M. L., Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Advances in Immunology 1983 34 141 212 2-s2.0-0020971452 (Pubitemid 14089437)
48. Jousilahti P., Salomaa V., Hakala K., Rasi V., Vahtera E., Palosuo T., The association of sensitive systemic inflammation markers with bronchial asthma. Annals of Allergy, Asthma and Immunology 2002 89 4 381 385 2-s2.0-0036824437 (Pubitemid 36188009)